Dr. Sato

Takami Sato, MD, Ph.D

Contact Dr. Sato

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
  2. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls
  3. PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma
  4. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
  5. Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes
  6. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
  7. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
  8. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  9. Co-Targeting HGF/cMET Signaling with MEK Inhibitors in metastatic uveal melanoma
  10. Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
  11. Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma
  12. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
  13. Immune check point inhibitors combination in melanoma: Worth the toxicity?
  14. Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T)
  15. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization
  16. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  17. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
  18. Successes and setbacks of early investigational drugs for melanoma
  19. Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma
  20. Biology of advanced uveal melanoma and next steps for clinical therapeutics